NCT06668701 Evaluation of the Naturalistic User Experience of the Website "ich Bin Alles"
| NCT ID | NCT06668701 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ludwig-Maximilians - University of Munich |
| Condition | Depressive Disorder |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2024-06-20 |
| Primary Completion | 2025-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2024-06-20 with a primary completion date of 2025-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Using a multi-method approach, the aim of this study is to investigate the naturalistic user experience and acceptance of the German website "ich bin alles". This website offers evidence-based information about the symptoms, causes, course, treatment, and prevention of youth depression. Another aim of this study is to determine whether the desired target groups of the website can be reached.
Eligibility Criteria
Inclusion Criteria: * 40 seconds website-use Exclusion Criteria: * no exclusion criteria
Frequently Asked Questions
Who can join the NCT06668701 clinical trial?
This trial is open to participants of all sexes, studying Depressive Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06668701 currently recruiting?
Yes, NCT06668701 is actively recruiting participants. Visit ClinicalTrials.gov or contact Ludwig-Maximilians - University of Munich to inquire about joining.
Where is the NCT06668701 trial being conducted?
This trial is being conducted at Munich, Germany.
Who is sponsoring the NCT06668701 clinical trial?
NCT06668701 is sponsored by Ludwig-Maximilians - University of Munich. The trial plans to enroll 300 participants.